Ignite Creation Date:
2024-05-06 @ 3:05 PM
Last Modification Date:
2024-10-26 @ 1:42 PM
Study NCT ID:
NCT04512716
Status:
RECRUITING
Last Update Posted:
2024-03-08
First Post:
2020-07-28
Brief Title:
Iomab-ACT a Pilot Study of 131-I Apamistamab Followed by CD19-Targeted CAR T-Cell Therapy for Patients with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell Lymphoma
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Memorial Sloan Kettering Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| HGBL Nos |
| B-ALL |
| DLBCL |
| B ALL |
| Dlbcl-Ci |
| DLBCL Unclassifiable |
| DLBCL Nos Genetic Subtypes |
| DLBCL Activated B-Cell Type |
| DLBCL Germinal Center B-Cell Type |
| Diffuse Large B-cell Lymphoma |
| HGBL |